Guangdong Hybribio Biotech Co.,Ltd.
Status: Publicly traded
Direct answer
Guangdong Hybribio Biotech Co.,Ltd. is publicly traded on SHZ under the ticker 300639.SZ.
Guangdong Hybribio Biotech Co., Ltd. engages in the research, development, production, and sale of nucleic acid molecular diagnostic products in China. It also provides on-site technical training and after-sales technical service support. The company was founded by Qiao Zhong Guan on June 13, 2003 and is headquartered in Chaozhou, China.
Can you invest in Guangdong Hybribio Biotech Co.,Ltd.?
Yes. Guangdong Hybribio Biotech Co.,Ltd. is publicly traded on SHZ under the ticker 300639.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Guangdong Hybribio Biotech Co.,Ltd.
Detailed equity research is provided by MarketSnap.